Duchenne muscular dystrophy (DMD) causes progressive muscle weakness. There is currently no cure for the disease; however, recent studies have suggested that a bioactive lipid, sphingosine-1-phosphate (S1P), might protect against eventual muscle degeneration. S1P is an inhibitor of histone deacetylases (HDACs), which could form the molecular basis of its protective role in DMD. To test this possibility, Hannele Ruohola-Baker and colleagues exploited Drosophila and mouse models of the disease. They reduced levels of Rpd3, the Drosophila homologue of HDAC2, and found that disease symptoms were alleviated. In DMD mice, symptoms were also improved upon treatment with a compound that increases levels of S1P and suppresses HDAC activity. Interestingly, this improvement correlated with the expression of two miRNAs involved in promoting regeneration and energy metabolism in skeletal muscle tissue. This cross-species analysis thereby provides important insights into the pathology of DMD and the therapeutic potential of S1P. Page 41
Skip Nav Destination
IN THIS ISSUE| 01 January 2014
Promoting skeletal muscle regeneration in mouse and fly models of DMD
Online Issn: 1754-8411
Print Issn: 1754-8403
Written by editorial staff. © 2014. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Dis Model Mech (2014) 7 (1): 1.
- Views Icon Views
Article Versions Icon
- Version of Record 01 January 2014
- Share Icon Share
- Search Site
Promoting skeletal muscle regeneration in mouse and fly models of DMD. Dis Model Mech 1 January 2014; 7 (1): 1. doi:
Download citation file: